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readmission occurred with a statistically signiﬁcant difference at 24
months (p<0.05), but no signiﬁcant differences in other follow-up
time (p >0.05). Follow up of 24 months, 10 patients in the A group
recurrence of angina pectoris (23.26%), non fatal myocardial infarc-
tion in 0 cases. The B group had recurrence of angina pectoris in 24
cases (42.86%) of 5 cases of non fatal myocardial infarction (12.5%), a
statistically signiﬁcant.
CONCLUSIONS An important basis for
1. IVUS examination can be used as critical lesion for interventional
therapy.
2. IVUS check the critical disease intervention to obtain a relatively
high success rate and good clinical outcome.
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OBJECTIVES Emerging studies suggest that patients with complex
coronary lesions undergoing percutaneous coronary intervention
(PCI) have more major adverse cardiac events (MACE) than do those
with simple ones. Intensive antiplatelet therapy could reduce recur-
rent ischemic events in the patients with complex lesions. In the
present study, we evaluated the safety and efﬁcacy of routine dual
antiplatelet therapy plus low-dose cilostazol in patients with complex
coronary lesions undergoing PCI.
METHODS A total of 127 patients with complex lesions undergoing
PCI in Cardiology Department of the Second Hospital of Tianjin
Medical University from October 2012 to April 2014 were randomized
to receive: dual (aspirin plus clopidogrel, DAPT, n ¼66) or triple
antiplatelet therapy (aspirin plus clopidogrel plus cilostazol, TAPT,
n¼61). Patients in the TAPT group received adjunctive cilostazol
(100mg loading, followed by 50mg BID) for 3-6 months. The primary
endpoint was composite major adverse cardiac events (MACE). The
complex coronary target lesions were deﬁned as at least one of
followings: left main disease, severe 3-vessel disease, chronic total
occlusion (CTO) lesions, true bifurcation lesion (Medina classiﬁca-
tion: 1.1.1), ostial lesions of main vessels and highly thrombotic
lesions.
RESULTS The 2 groups had similar baseline clinical and angio-
graphic characteristics. One-year clinical outcomes showed that the
TAPT group had signiﬁcantly lower incidence of myocardial
infarction (1.6% vs 13.6%, P ¼0.018) and MACE (1.6% vs 16.7%,
P ¼0.004) than did the DAPT group. The DAPT group had 2 cases of
stent thrombosis, while the TAPT group didn’t have. Furthermore,
low-dose adjunctive cilostazol didn’t signiﬁcantly increase the
incidence of bleeding events (26.2% vs 19.7%, P ¼0.381) regardless
of major (4.9% vs 4.5%, P ¼0.921) or minor (21.3% vs 15.2%,
P ¼0.368) events.
CONCLUSIONS Low-dose adjunctive cilostazol seems to be superior
to dual antiplatelet therapy in reducing recurrent ischemic events
with similar rates of bleeding events in patients with complex coro-
nary lesions. Further study with larger population will be needed to
get the deﬁnite conclusions.
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OBJECTIVES To investigate the relationship of serum C1q/TNF-
related protein 5 (CTRP5) with coronary artery restenosis after
drug-eluting stent (DES) based percutaneous coronary intervention
(PCI).
METHODS Clinical characteristics, biochemical measurements, med-
ical treatments, left ventricular ejection fraction (LVEF), serum
CTRP5and coronary interventional features were assessed in
258 consecutive patients with angiographic ISR and 260 age- and
sex-matched patients without ISR at one-year after PCI withsirolimus-eluting stent implantation. Multivariate Logistic regression
analysis was performed to determine the independent factors for ISR.
RESULTS Compared with non-ISR patients, those with ISR had higher
incidence of prior myocardial infarction and were more likely to be
diabetic and cigarette smokers. Serum levels of low-density lipopro-
tein cholesterol (LDL-C), apoliprotein B, high-sensitivity C-reactive
protein, and glycosylated hemoglobin were higher, but LVEF was
lower in patients with ISR. Despite similar degree of coronary disease
and site of stent implantation, stent diameter was smaller, stent
length was longer, and bifurcation stenting was more common in
patients with ISR. The level of CTRP5 in ISR group was signiﬁcantly
higher than that in the control group (P < 0.05). Multivariate Logistic
regression analysis revealed that prior myocardial infarction
(OR¼3.23), diabetes (OR¼2.33), cigarette smoking (OR¼1.85), elevated
hs-CRP(OR¼1.06), LDL-C (OR¼1.30), and CTRP5 (OR¼1.51), and greater
stent length (OR¼1.08) were independent risk factors for ISR, whereas
stent diameter (OR¼0.39) and LVEF (OR¼0.94) were inversely asso-
ciated with ISR (all P<0.05).
CONCLUSIONS ISR after sirolimus-eluting stent implantation was
related to multiple clinical and coronary angiographic and interven-
tional factors. Elevated serum CTRP5 level is an independent pre-
dictor for ISR. Optimal control of traditional risk factors and
improvement of left ventricular function were crucial in reducing ISR,
particularly for patients with small vessel disease, long lesion (stents)
and bifurcation stenting. AR-SA’>, apoliprotein B, high-sensitivity C-
reactive protein, and glycosylated hemoglobin were higher, but LVEF
was lower in patients with ISR. Despite similar degree of coronary
disease and site of stent implantation, stent diameter was smaller,
stent length was longer, and bifurcation stenting was more common
in patients with ISR. The level of CTRP5 in ISR group was signiﬁcantly
higher than that in the control group (P < 0.05). Multivariate Logistic
regression analysis revealed that prior myocardial infarction
(OR¼3.23), diabetes (OR¼2.33), cigarette smoking (OR¼1.85), elevated
hs-CRP(OR¼1.06), LDL-C (OR¼1.30), and CTRP5 (OR¼1.51), and greater
stent length (OR¼1.08) were independent risk factors for ISR, whereas
stent diameter (OR¼0.39) and LVEF (OR¼0.94) were inversely asso-
ciated with ISR (all P<0.05).
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OBJECTIVES Coronary bifurcations (CB) are frequently encountered
and remain to be one of the most challenging lesion subsets for cor-
onary intervention. The main strategy nowadays to treat CB lesions
is the crossover technique. In brief, a stent was ﬁrstly implanted in
the main vessel and then branch kissing balloon or the stent-angio-
plasty performed in the side branch according to the side branch
stenosis.
METHODS Detailed steps are as follows:
(1) both SB and the main vessel are wired and then the small-
diameter balloon is advanced into the SB beforehand and makes sure
that the proximal portion of the balloon protrudes into the main
branch at a distance of 2 mm.
(2) After the main vessel predialation and stent implantation,
release the stent with minimum named pressure (8-10 atm).
(3) During the main vessel stent released with minimum named
pressure (10 atm), Sequent balloon in the ostium of side branch is
opening with6-8atm.
(4) After the 2.015 mm balloon was removed, the main vessel
stent balloon released with more pressure (14-16 atm), or A NC-
Sprinter balloon was put into the stent and post-dilated with 16 atm
pressure.
Here we present one case of coronary heart disease, which per-
formed this approach for side coronary bifurcations.
RESULTS The branch balloon opening technique has the following
advantages over the traditional side branch wire protection. It can
prevent the ostium of the side branch from aggravation. The stent
implantation in the main vessel makes the plaque shift or change the
kind of the stenosis, which will leads the compromise of the ostiumof
the side branch, occlusion or severe stenosis. Though there is report
that the jailed balloon can protect the ostium of the side branch, but
the just keep the balloon there or balloon the stent ﬁrst. Here we used
the technique that balloon open ﬁrst and then stent in nominal
pressure, the key point is that the opened balloon in the ostium can
